Researchers at MD Anderson Cancer Center have used spatial transcriptomics to chart the internal architecture of ...

How can human biology data improve target selection? Learn how one discovery programme identified a potential new treatment ...

Jayson Uffens is Co-founder, Chairman and Chief Technology Officer at GATC Health, where he leads the development of AI ...

A computational biology-derived compound has shown promise in preclinical models by simultaneously improving levodopa ...

Crown Bioscience has become the ninth member of the Critical Path Institute’s NAMs Developer Coalition, contributing patient-derived xenograft models, tumour organoids and biomarker analysis ...

A novel epigenetic therapy has demonstrated activity against treatment-resistant acute myeloid leukaemia in preclinical ...

Engineers at MIT have developed a technique to direct blood vessel growth using mechanical forces, offering a potential ...

A structure-guided peptide vaccine targeting PCSK9 has demonstrated durable antibody responses and reduced LDL cholesterol ...

A new review examines how advances in drug design, PROTAC degraders and combination therapies are reviving the clinical ...

A new review finds that next-generation BET-targeted therapies, including selective inhibitors and PROTACs, are addressing ...

In part II of his conversation with Dr Nick Lynch, founder of Curlew Research, Raminderpal Singh asks the uncomfortable ...

Ovarian cancer has long proved difficult to treat. Could the answer lie within the disease itself? Discover how synthetic ...